Venable LLP is pleased to announce that David K. Barr has joined the firm as a partner in the IP Litigation – Life Sciences Group in the New York office. Mr. Barr focuses on patent litigation, adversarial patent office proceedings, transactions, and counseling for life sciences clients.
Matthew T. McLaughlin, partner-in-charge of Venable’s New York office, said, “Venable’s presence in New York has never been stronger. As we settle into our new state-of-the-art office space, we’re thrilled to welcome an attorney of David’s caliber. His practice will be a great addition to our already robust IP Litigation – Life Sciences Group.”
Mr. Barr has litigated and tried patent cases in the federal district courts before both the bench and juries in matters involving small-molecule chemistry, therapeutic antibodies, cell and gene therapies, diagnostics, and medical devices, including Hatch-Waxman and biologics litigation, and has represented clients before the Court of Appeals for the Federal Circuit and the U.S. Supreme Court. He frequently coordinates with his clients’ foreign patent counsel when their matters have international scope and regularly advises on and litigates trade secret issues for his life sciences clients. Mr. Barr also has extensive experience in life sciences transactions, including mergers and acquisitions, asset purchases, and licensing and collaboration agreements. He is known for bringing to bear his deep patent litigation experience and knowledge of FDA regulatory issues in analyzing complex life sciences transactions, both in due diligence and in drafting patent licenses and related agreements. Mr. Barr is also the co-author and co-editor of the Practicing Law Institute’s treatise on Pharmaceutical and Biotech Patent Law and co-chairs an annual program for PLI on Developments in Pharmaceutical and Biotech Patent Law.
Scott K. Reed, a co-chair of the IP Litigation – Life Sciences Group, said, “David has exceptional experience not only as a litigator, but also with providing comprehensive counsel to many of the top players in the life sciences industry. The breadth of his practice will be a major asset to our clients.”
“Venable has established itself as a powerhouse in the IP space. Our attorneys are known as seasoned trial lawyers with extensive technical knowledge, and David is no different. His exemplary record of helping clients succeed, in both the courtroom and boardroom, makes him a wonderful fit for our group,” said William E. Solander, a co-chair of the IP Litigation – Life Sciences Group.
Commenting on his move to Venable, Mr. Barr said, “Venable has a deep bench of scientifically trained patent lawyers that clients want on their team. I am looking forward to joining and working with this vibrant group of highly accomplished patent lawyers and continuing to grow my practice.”
Mr. Barr received his J.D. from The George Washington University School of Law and his B.S. in biological sciences from Cornell University.
Venable LLP is an American Lawyer Global 100 law firm headquartered in Washington, DC that serves as primary counsel to a worldwide clientele of large and mid-sized organizations, nonprofits, high-net-worth entrepreneurs, and other individuals. With more than 850 professionals across the country, including in California, Delaware, Florida, Illinois, Maryland, New York, Virginia, and Washington, DC, the firm strategically advances its clients’ objectives in the United States and around the globe. Venable advises clients on a broad range of business and regulatory law, legislative affairs, complex litigation, and the full range of intellectual property disciplines. For more information, please visit https://www.venable.com/.
